Erlotinib 150 mg

What is Erlotinib 150 mg?

Erlotinib 150 mg is a prescription medication containing the active ingredient erlotinib. It is primarily prescribed for the treatment of certain types of cancers such as non-small cell lung cancer and pancreatic cancer. Manufactured by Cipla Limited, a well-known pharmaceutical company, Erlotinib 150 mg is recognized for its targeted approach to cancer therapy.

This medication is designed to work by inhibiting specific proteins that promote cancer cell growth. Erlotinib is available in tablet form and is used under medical supervision due to its potent effects and need for careful dosage control. Patients prescribed this drug should follow their healthcare provider’s instructions closely to maximize effectiveness while minimizing side effects.

Uses of Erlotinib 150 mg

• Treatment of non-small cell lung cancer (NSCLC), alongside options like cisplatin
• Management of locally advanced or metastatic pancreatic cancer
• Used as a monotherapy or in combination with other chemotherapy agents such as gemcitabine
• Suitable for patients with specific genetic markers indicating sensitivity to erlotinib

How Erlotinib 150 mg Works

Erlotinib is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR) involved in the signaling pathways regulating cell division and survival. By blocking the EGFR, Erlotinib 150 mg disrupts critical growth signals in cancer cells, slowing or stopping their proliferation. This targeted mechanism helps to reduce the size and spread of tumors, making it an important option in oncological care.

Benefits of Erlotinib 150 mg

• Specifically targets cancer cells, reducing damage to normal cells
• Effective in slowing progression of certain lung and pancreatic cancers
• Orally administered, facilitating easier compliance compared to intravenous therapies
• Can be used alongside other treatments for enhanced efficacy, and a lower strength is available as Erlotinib 100 mg
• Manufactured by Cipla Limited ensuring quality and reliability

Dosage and Administration

The recommended dose of Erlotinib 150 mg is usually one tablet taken once daily. It should be taken on an empty stomach at least one hour before or two hours after meals to enhance absorption. Patients should swallow the tablet whole with water and avoid breaking or crushing it. Regular monitoring by healthcare professionals is essential to adjust the dosage as needed and to manage any adverse effects, while this targeted therapy booklet for lung cancer describes what to expect.

Who Should Use Erlotinib 150 mg?

Erlotinib 150 mg is appropriate for adults diagnosed with non-small cell lung cancer or pancreatic cancer who have been evaluated by an oncologist. It is especially recommended for patients whose cancer cells test positive for EGFR mutations, as they are more likely to respond positively to this targeted therapy. Usage should always be under the guidance of a qualified healthcare provider.

Who Should Avoid Erlotinib 150 mg?

Patients with known hypersensitivity to erlotinib or any of its components should avoid this medication. It is also not suitable for pregnant or breastfeeding women unless explicitly recommended by a doctor. Individuals with severe liver or kidney impairment must discuss risks with their healthcare provider before starting treatment. Additionally, caution is necessary in patients taking other medications that might interact adversely with Erlotinib.

Side Effects

• Rash or acne-like skin eruptions
• Diarrhea
• Loss of appetite
• Fatigue or weakness
• Nausea and vomiting
• Mouth sores
• Dry skin
• Eye irritation
• Shortness of breath in rare cases
• Elevated liver enzymes

Safety Advice

• Follow prescribed dosage strictly; do not self-adjust
• Inform your doctor about all current medications and supplements
• Avoid exposure to sunlight as erlotinib can increase sensitivity
• Report any severe skin reactions or respiratory symptoms immediately
• Do not discontinue the medication without consulting your healthcare provider
• Regular blood tests may be required to monitor liver function
• Ensure adequate hydration to reduce the risk of gastrointestinal side effects

Drug Interactions

• Anticoagulants like warfarin
• Medications that induce or inhibit CYP3A4 enzymes
• Rifampicin and phenytoin
• St. John’s Wort
• Certain proton pump inhibitors and antacids
• Other chemotherapy agents and kinase inhibitors such as sorafenib

Storage Instructions

Store Erlotinib 150 mg tablets in a cool, dry place away from direct sunlight. Keep the medication in its original container tightly closed and out of reach of children. Avoid storing in bathrooms or humid areas. The recommended storage temperature is between 15°C to 30°C (59°F to 86°F).

Where to buy Erlotinib 150 mg in Canada?

In Canada, Erlotinib 150 mg can be obtained through licensed pharmacies with a valid prescription. It is available both at hospital pharmacies and reputable online Canadian pharmacy platforms. Patients should ensure they purchase from authorized suppliers to guarantee the authenticity and quality of the medication. Always consult your oncologist or healthcare provider to obtain the appropriate prescription before purchasing.

Frequently Asked Questions (FAQ)

Is Erlotinib 150 mg available in Canada?

Yes, Erlotinib 150 mg is available in licensed Canadian pharmacies with a valid prescription from a healthcare professional.

What is the price of Erlotinib 150 mg in Canada?

The price varies depending on the pharmacy and specific health coverage. It is advisable to check with local pharmacies or healthcare providers for accurate pricing.

What happens if I miss a dose?

If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for the missed one.

Where can I find Erlotinib 150 mg for sale?

Erlotinib 150 mg can be purchased at hospital pharmacies and certified online pharmacies in Canada. Always ensure the supplier is reputable and requires a prescription.

Can I take Erlotinib 150 mg with food?

It is recommended to take Erlotinib on an empty stomach to improve absorption. Take it at least one hour before or two hours after meals.

Does Erlotinib 150 mg cause hair loss?

Hair loss is uncommon with Erlotinib, but some patients may experience mild hair thinning or changes in hair texture.

How long does it take to see results with Erlotinib 150 mg?

The response time can vary; some patients may notice improvement within weeks, but continuous use as directed by your doctor is essential for optimal effect.

Conclusion

Erlotinib 150 mg is a targeted cancer therapy offering effective treatment options for non-small cell lung cancer and pancreatic cancer patients. Manufactured by Cipla Limited, it combines a potent mechanism of action with manageable administration. When used responsibly under medical supervision, Erlotinib 150 mg can contribute significantly to cancer management, improving patient outcomes while minimizing harmful effects.